| Q30499045 | 1999 Canadian recommendations for the management of hypertension. Task Force for the Development of the 1999 Canadian Recommendations for the Management of Hypertension |
| Q33895484 | A technology-based quality innovation to identify undiagnosed hypertension among active primary care patients |
| Q38970451 | Ambulatory Blood Pressure Variability Increases Over a 10-Year Follow-Up in Community-Dwelling Older People |
| Q36536301 | Ambulatory blood pressure in hypertensive patients with left ventricular hypertrophy: efficacy of first-line combination perindopril/indapamide therapy |
| Q73150706 | Ambulatory blood pressure monitoring |
| Q83104339 | Ambulatory blood pressure variability and brachial-ankle pulse wave velocity in untreated hypertensive patients |
| Q45772264 | Association of home and ambulatory blood pressure changes with changes in cardiovascular biomarkers during antihypertensive treatment |
| Q34026662 | Blood pressure measurement: clinic, home, ambulatory, and beyond |
| Q37147258 | Blood pressure measurements taken by patients are similar to home and ambulatory blood pressure measurements |
| Q57085343 | Breastfeeding leads to lower blood pressure in 7-year-old Japanese children: Tohoku Study of Child Development |
| Q45057509 | Cardiovascular risk and ambulatory blood pressure |
| Q34213896 | Clinical Implications of Ambulatory and Home Blood Pressure Monitoring |
| Q30499043 | Clinical problem solving based on the 1999 Canadian recommendations for the management of hypertension. |
| Q38607522 | Clinical value of ambulatory blood pressure in pediatric patients after renal transplantation |
| Q36868611 | Comparing the effects of white coat hypertension and sustained hypertension on mortality in a UK primary care setting |
| Q36282431 | Diagnosis and treatment of high blood pressure. New directions and new approaches: 1999 Canadian recommendations for management of hypertension |
| Q34199944 | Diagnosis of high blood pressure in children by means of ambulatory blood pressure monitoring |
| Q37739821 | Diurnal blood pressure variation and cardiovascular prognosis in a community-based study of Ohasama, Japan |
| Q42669811 | Effect of hospitalization on 24-h ambulatory blood pressure of hypertensive patients |
| Q79817369 | Effects of amlodipine and valsartan on vascular damage and ambulatory blood pressure in untreated hypertensive patients |
| Q33804982 | Evidence based treatment of hypertension. Measurement of blood pressure: an evidence based review |
| Q24792323 | Favorable patient acceptance of ambulatory blood pressure monitoring in a primary care setting in the United States: a cross-sectional survey |
| Q73508820 | Gene polymorphism of the renin-angiotensin system associates with risk for lacunar infarction. The Ohasama study |
| Q81504827 | High-dose monotherapy vs low-dose combination therapy of calcium channel blockers and angiotensin receptor blockers in mild to moderate hypertension |
| Q74060337 | Home blood pressure: accuracy is independent of monitoring schedules |
| Q38314802 | Human G-protein beta3 subunit variant is associated with serum potassium and total cholesterol levels but not with blood pressure |
| Q26745487 | Hypertension in Canada: Past, Present, and Future |
| Q35400901 | Is nocturnal blood pressure reduction the secret to reducing the rate of progression of hypertensive chronic kidney disease? |
| Q37449065 | Location not quantity of blood pressure measurements predicts mortality in hemodialysis patients |
| Q75419077 | Masked hypertension--a new entity and challenge for clinical hypertension research and management |
| Q35670494 | Morning hypertension in treated hypertensives: baseline characteristics and clinical implications. |
| Q35135059 | Nighttime hospital blood pressure--a predictor of death, ESRD, and decline in GFR |
| Q90042591 | Once versus twice daily antihypertensive medications for the control of nocturnal blood pressure: a comparative study |
| Q36249768 | Prevalence and risk factors for cardiovascular disease among chronic kidney disease patients: results from the Chinese cohort study of chronic kidney disease (C-STRIDE). |
| Q37387520 | Preventing misdiagnosis of ambulatory hypertension: algorithm using office and home blood pressures |
| Q34142891 | Principles and Techniques of Blood Pressure Measurement |
| Q74466749 | Principles and techniques of blood pressure measurement |
| Q81857814 | Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice |
| Q34669329 | Prognostic significance of the morning blood pressure surge in clinical practice: a systematic review |
| Q53025053 | Prognostic significance of variability in ambulatory and home blood pressure from the Ohasama study. |
| Q58419321 | Prognostic value of treatment-induced changes in twenty-four-hour mean and pulse pressures in adult hypertensive patients |
| Q40942671 | Relationship between maternal gestational hypertension and home blood pressure in 7-year-old children and their mothers: Tohoku Study of Child Development |
| Q77704953 | Risk of cardiovascular disease in relation to achieved office and ambulatory blood pressure control in treated hypertensive subjects |
| Q33960573 | Role of ambulatory and home blood pressure recording in clinical practice |
| Q35184917 | Screening for high blood pressure: a review of the evidence for the U.S. Preventive Services Task Force |
| Q48807353 | Silent and clinically overt stroke in older Japanese subjects with white-coat and sustained hypertension. |
| Q24793325 | The Blood Pressure "Uncertainty Range" - a pragmatic approach to overcome current diagnostic uncertainties (II) |
| Q24815566 | The BpTRU automatic blood pressure monitor compared to 24 hour ambulatory blood pressure monitoring in the assessment of blood pressure in patients with hypertension |
| Q37846894 | The differential effects of EPA and DHA on cardiovascular risk factors |
| Q35848359 | The evolution and refinement of traditional risk factors for cardiovascular disease |
| Q36586179 | Twenty four hour ambulatory blood pressure monitoring: a new tool for determining cardiovascular prognosis |
| Q97568823 | Twenty-four-hour versus clinic blood pressure levels as predictors of long-term cardiovascular and renal disease outcomes among African Americans |
| Q55387081 | Understanding short-term blood-pressure-variability phenotypes: from concept to clinical practice. |
| Q34365058 | Using out of office blood pressure monitoring in the management of hypertension |
| Q26784487 | What is the evidence base for diagnosing hypertension and for subsequent blood pressure treatment targets in the prevention of cardiovascular disease? |
| Q78039170 | [Ambulatory monitoring of blood pressure during 24, 48, 72 hours. Which is the reasonable limit?] |
| Q73592173 | [Evaluation and validation of Omron Hem 705 CP and Hem 706/711 monitors for self-measurement of blood pressure] |
| Q73829707 | [Evolution of white coat hypertension to sustained hypertension. One year follow-up by ambulatory blood pressure monitoring] |
| Q78376890 | [Useful parameters for the management of hypertensive patients] |
| Q34766294 | β2 adrenergic receptor polymorphisms and nocturnal blood pressure dipping status in the Wisconsin Sleep Cohort Study |